Viral load testing according to experts is crucial in the treatment of HIV as it helps in making treatment decisions which in the end help the patient to suppress the virus and improve their quality of life.
The Uganda Virus Research Institute (UVRI) has embarked on a
new study to establish how effective it is to use a point of care test in
detecting virus levels in children and adolescents. At the moment, viral load testing is
conducted only at the Uganda National Public Health Laboratory in Butabika.
Viral load testing according to experts is crucial in
the treatment of HIV as it helps in making treatment decisions which in the end
help the patient to suppress the virus and improve their quality of life.
Dr Benard Kikaire, a UVRI based researcher says that with the existing centralized monitoring of
a viral load where the samples have to be moved to Kampala, treatment
decisions are delayed and many times suffer challenges such as delayed delivery
of results and mislabeling of samples among others.
For him, the new innovation involving one receiving their
results about 70 minutes after the samples are drawn at the facility will likely
be a game-changer in care since Uganda is currently struggling to reach the 95-95-95 UNAIDS strategy of having everyone on treatment achieving 95 per cent suppression
of the virus. The study will also be conducted in Kenya, Tanzania and Rwanda, covering a total of 2,100 children.
//Cue in; “Currently the blood…
Cue out…we are missing.”//
Currently, in Uganda, up to 25 per cent of children on treatment are
not suppressing the virus, something that is attributed to non-adherence to
anti-retroviral drugs. According to the Ministry of Health guidelines, adults on HIV
treatment are supposed to be tested every year to monitor whether they are suppressing.
On the other hand, children are supposed to be tested every after six months but
only a few turn up for this regular monitoring.
//Cue in; ”We are considering…
Cue out…of these children.”//
According to UVRI, the new study will be done for a duration
of four years whereby in Uganda, six health facilities sampled from across the
country will be involved and three will be equipped with the
M-Pima testing machines for point care monitoring and three other sites will be analyzed
on effectiveness in using the already existing centralized monitoring.
Dr Joseph Lutakome, the Principal investigator on the study
says each child enrolled on the study will participate for a year. Apart from
testing effectiveness in detecting viral load, they are also analyzing to
see if M-Pima is a new technology in diagnosis that can be used well in both urban and
rural settings in addition to whether it’s generally acceptable by the health
According to specifications on the test kit, they don’t require
cold chain storage to operate and it detects both HIV type 1 and type II strains
that exist in the country.
Dr Charles Olaro, the Director
Curative Health Services in the Ministry of Health said the study is timely
considering that the country is now aiming to reach the 95 95 95 goals which
stand for 95 per cent of the people in the country knowing their status, 95 per cent of the positive
being on treatment and 95 per cent of those on treatment being able to suppress their
Currently, he says among adolescents of 10 to 19 years,
suppression levels stand at 61 per cent whereas for children it’s low at about 50 per cent. For him, once this study, if successful, will help inform
policy change for treatment in especially children. He added that research showing undetectable viral loads means one will not only be at a lower risk of
developing AIDS but also their risk of developing resistance to ARVs will be